Search Results - Pond, G

C-statistic: A brief explanation of its construction, interpretation and limitations by Caetano, S.J., Sonpavde, G., Pond, G.R.

“…A brief explanation, interpretation and limitations of clinical statistics is presented. Model validation has traditionally been performed by splitting the…”
Get full text

Statistical issues in the use of dynamic allocation methods for balancing baseline covariates by Pond, G R

“…Background: The procedure for allocating patients to a treatment arm in comparative clinical trials is frequently chosen with only minor deliberation. This…”
Get full text

Basic animal nutrition and feeding: W. G. Pond, D. C. Church, K. R. Pond by Pond, W. G, Church, D. C, Pond, K. R

Get more information

Animal welfare in animal agriculture: husbandry, stewardship, and sustainability in animal production / edited by Wilson G. Pond, Fuller W. Bazer, and Bernard E. Rollin by Pond, Wilson G, Bazer, Fuller Warren, Rollin, Bernard E

Get more information

Oncologists and medical assistance in dying: where do we stand? Results of a national survey of Canadian oncologists by Chandhoke, G, Pond, G, Levine, O, Oczkowski, S

“…In June 2016, when the Parliament of Canada passed Bill C-14, the country joined the small number of jurisdictions that have legalized medical assistance in…”
Get full text

Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer by Tannock, I.F., Pond, G.R.

Get full text

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy by Balitsky, Amaris, Pond, G R, Davies, G A, Fraser, G, Kouroukis, T, Levine, M, Meyer, R M, Foley, R

“… FACT-Lym includes FACT-G (physical, social, emotional and functional well-being domains…”
Get full text

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK by Storozhuk, Y, Hopmans, S N, Sanli, T, Barron, C, Tsiani, E, Cutz, J-C, Pond, G, Wright, J, Singh, G, Tsakiridis, T

“…Background: We examined the potential of metformin (MET) to enhance non-small cell lung cancer (NSCLC) responses to ionising radiation (IR). Methods: Human…”
Get full text

Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer by GAN, Hui K, YOU, Benoit, POND, Gregory R, CHEN, Eric X

“…In designing phase III randomized clinical trials (RCTs), the expected magnitude of the benefit of the experimental therapy (δ) determines the number of…”
Get full text

Dietary supplementation with cholesterol and docosahexaenoic acid affects concentrations of amino acids in tissues of young pigs by Li, Peng, Kim, Sung Woo, Li, Xilong, Datta, Sujay, Pond, Wilson G, Wu, Guoyao

“…Cholesterol and docosahexaenoic acid (DHA) are important nutrients for neural development of infants. However, little is known about the effect of cholesterol…”
Get full text

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials by Templeton, A.J., Vera-Badillo, F.E., Wang, L., Attalla, M., De Gouveia, P., Leibowitz-Amit, R., Knox, J.J., Moore, M., Sridhar, S.S., Joshua, A.M., Pond, G.R., Amir, E., Tannock, I.F.

“…Multiple factors can influence outcomes of patients receiving identical interventions in clinical trials and in routine practice. Here, we compare outcomes of…”
Get full text

Cognitive function and fatigue after diagnosis of colorectal cancer by Vardy, J., Dhillon, H.M., Pond, G.R., Rourke, S.B., Xu, W., Dodd, A., Renton, C., Park, A., Bekele, T., Ringash, J., Zhang, H., Burkes, R., Clarke, S.J., Tannock, I.F.

“…Cognitive impairment and fatigue have been associated with cancer and its treatment. We present baseline data from a large longitudinal study that evaluates…”
Get full text

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer by Clemons, M., Fergusson, D., Simos, D., Mates, M., Robinson, A., Califaretti, N., Zibdawi, L., Bahl, M., Raphael, J., Ibrahim, M.F.K., Fernandes, R., Pitre, L., Aseyev, O., Stober, C., Vandermeer, L., Saunders, D., Hutton, B., Mallick, R., Pond, G.R., Awan, A., Hilton, J.

“…The optimal duration of filgrastim as primary febrile neutropenia (FN) prophylaxis in early breast cancer patients is unknown, with 5, 7 or 10 days being…”
Get full text

Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy by Bane, A.L., Whelan, T.J., Pond, G.R., Parpia, S., Gohla, G., Fyles, A.W., Pignol, J.-P., Pritchard, K.I., Chambers, S., Levine, M.N.

“…To determine whether tumor grade, molecular subtype and hypoxia predict response to hypofractionated versus standard radiotherapy (RT) following…”
Get full text

Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis by Parvez, E., Bogach, J., Kirkwood, D., Pond, G., Doumouras, A., Hodgson, N., Levine, M.

“…Introduction As immigrant women face challenges accessing health care, we hypothesized that immigration status would be associated with fewer women with breast…”
Get full text

ASO Visual Abstract: Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis by Parvez, E., Bogach, J., Kirkwood, D., Pond, G., Doumouras, A., Hodgson, N., Levine, M.

Get full text

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas by DURAN, I, KORTMANSKY, J, BIRLE, D, POND, G. R, ARBOINE, D, DANCEY, J, AVIEL-RONEN, S, TSAO, M.-S, HEDLEY, D, SIU, L. L, SINGH, D, HIRTE, H, KOCHA, W, GOSS, G, LE, L, OZA, A, NICKLEE, T, HO, J

“…Standard cytotoxic treatments for neuroendocrine tumours have been associated with limited activity and remarkable toxicity. A phase II study was designed to…”
Get full text

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy by VARDY, J, CHIEW, K. S, GALICA, J, POND, G. R, TANNOCK, I. F

“…The role of dexamethasone to reduce delayed emesis following highly emetogenic chemotherapy is proven, but there is less evidence of benefit after…”
Get full text

Fertility risk discussions in young patients diagnosed with colorectal cancer by Kumar, A, Merali, A, Pond, G R, Zbuk, K

“…In 2006, the American Society of Clinical Oncology established guidelines on fertility preservation in cancer patients, but recent data suggest that the…”
Get full text

Prognostic ability of HR-QoL parameters in metastatic renal cell carcinoma (mRCC) by Grünwald, V., Dietrich, M., Pond, G.R.

Get full text